Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,820.00p
   
  • Change Today:
    -4.00p
  • 52 Week High: 2,506.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 35,111
  • Market Cap: £1,201.80m
  • RiskGrade: 128

Thursday broker round-up

By Caoimhe Toman

Date: Thursday 25 Feb 2021

LONDON (ShareCast) - (Sharecast News) - Medica Group: Liberum initiates at buy with a target price of 200p.



Reckitt Benckiser: Berenberg reiterates buy with a target price of 8,385p.

Lloyds Banking Group: Berenberg reiterates hold with a target price of 38p.

Grafton Group: Canaccord reiterates buy with a target price of 1,010p.

easyJet: Deutsche Bank reiterates buy with a target price of 1,000p.

Wizz Air: Deutsche Bank reiterates buy with a target price of 5,650p.

Biffa: Peel Hunt reiterates hold with a target price of 240p.

Genus: Peel Hunt reiterates buy with a target price of 5,500p.

Shaftesbury: Liberum reiterates hold with a target price of 565p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,820.00p
Change Today -4.00p
% Change -0.22 %
52 Week High 2,506.00
52 Week Low 1,637.00
Volume 35,111
Shares Issued 66.03m
Market Cap £1,201.80m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average
96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average
Price Trend
55.98% below the market average55.98% below the market average55.98% below the market average55.98% below the market average55.98% below the market average
9.43% above the sector average9.43% above the sector average9.43% above the sector average9.43% above the sector average9.43% above the sector average
Income
83.33% below the market average83.33% below the market average83.33% below the market average83.33% below the market average83.33% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
66.43% below the market average66.43% below the market average66.43% below the market average66.43% below the market average66.43% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 07-Jun-2024

Time Volume / Share Price
16:35 18,618 @ 1,820.00p
16:35 116 @ 1,820.00p
16:35 4 @ 1,820.00p
16:35 91 @ 1,820.00p
16:35 284 @ 1,820.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page